Onureg Tablet, Film Coated
Product Images NDC 59572-730

4 FDA label images from Celgene Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Onureg (NDC 59572-730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Onureg-chem-structure (Onureg Chem Structure)

Onureg-chem-structure (Onureg Chem Structure)
Chemical structure of azacitidine, the active ingredient in ONUREG, shown as a molecular diagram with atoms and bonds representing the nucleoside analog structure.*
FDA Label Image

Onureg-os-quazar (Onureg Os Quazar)

Onureg-os-quazar (Onureg Os Quazar)
A Kaplan-Meier survival curve comparing survival probabilities over time (in months) from randomization between ONUREG and placebo groups. The graph shows survival probability on the y-axis and time from randomization on the x-axis. The chart includes a table showing the number of patients at risk at various time points for both ONUREG and placebo groups, with events and censored data indicated.*
FDA Label Image

Onureg-200-carton (Onureg 200 Carton)

Onureg-200-carton (Onureg 200 Carton)
ONUREG 200 mg film-coated tablets packaging label showing the proprietary name, generic name azacitidine, and strength 200 mg. The label includes manufacturer information for Bristol-Myers Squibb and storage instructions. The package is for oral administration and contains one blister card with seven tablets. The design includes the ONUREG logo and highlights the product as a prescription drug marked with a caution for hazardous agent.*
FDA Label Image

Onureg-300-carton (Onureg 300 Carton)

Onureg-300-carton (Onureg 300 Carton)
ONUREG 300 mg film-coated tablets packaging label for oral azacitidine. The carton indicates each tablet contains 300 mg of azacitidine and comes in a blister card containing 7 tablets. Manufactured by Bristol-Myers Squibb Company, the label includes storage instructions, an NDC number, and warnings such as 'Rx only' and 'CAUTION: Hazardous Agent.' The label prominently features the ONUREG name and logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.